N. Pavlidis

2.8k total citations · 1 hit paper
38 papers, 1.5k citations indexed

About

N. Pavlidis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, N. Pavlidis has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in N. Pavlidis's work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Treatment and Pharmacology (6 papers). N. Pavlidis is often cited by papers focused on Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Treatment and Pharmacology (6 papers). N. Pavlidis collaborates with scholars based in Greece, United Kingdom and Spain. N. Pavlidis's co-authors include Davide Mauri, John P. A. Ioannidis, Enriqueta Felip, Rolf A. Stahel, J. Wanders, Steven Kaplan, Patrick Schöffski, H. R. Franklin, Thomas Cerny and Ron Epelbaum and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

N. Pavlidis

38 papers receiving 1.5k citations

Hit Papers

Neoadjuvant Versus Adjuvant Systemic Treatment in Breast ... 2005 2026 2012 2019 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
    2005 847 citations Davide Mauri, N. Pavlidis et al. JNCI Journal of the National Cancer Institute profile →

Peers

N. Pavlidis
Remedios Penetrante United States
Catharina Wenzel Austria
Christian Borel France
M Jouve France
Claudia Maggi Italy
Leigh Marcus United States
Isabelle Veys Belgium
Carlo Messina Italy
V. Weinberg United States
Emer O. Hanrahan United States
Remedios Penetrante United States
N. Pavlidis
Citations per year, relative to N. Pavlidis N. Pavlidis (= 1×) peers Remedios Penetrante

Countries citing papers authored by N. Pavlidis

Since Specialization
Citations

This map shows the geographic impact of N. Pavlidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Pavlidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Pavlidis more than expected).

Fields of papers citing papers by N. Pavlidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Pavlidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Pavlidis. The network helps show where N. Pavlidis may publish in the future.

Co-authorship network of co-authors of N. Pavlidis

This figure shows the co-authorship network connecting the top 25 collaborators of N. Pavlidis. A scholar is included among the top collaborators of N. Pavlidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Pavlidis. N. Pavlidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Boussios, Stergios & N. Pavlidis. (2013). Renal cell carcinoma in pregnancy: a rare coexistence. Clinical & Translational Oncology. 16(2). 122–127. 20 indexed citations
3.
Pavlidis, N., et al.. (2011). The History of Oncology by Theo Wagener. Annals of Oncology. 22(8). 1933–1935. 2 indexed citations
4.
Liberopoulos, Evangelos, et al.. (2007). Persistent Erythema Multiforme in a Patient with Extrahepatic Cholangiocarcinoma. Oncology. 73(1-2). 127–129. 8 indexed citations
5.
Mauri, Davide, N. Pavlidis, & John P. A. Ioannidis. (2005). Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis. JNCI Journal of the National Cancer Institute. 97(3). 188–194. 847 indexed citations breakdown →
6.
Felip, Enriqueta, N. Pavlidis, & Rolf A. Stahel. (2005). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC). Annals of Oncology. 16. i30–i31. 19 indexed citations
7.
Felip, Enriqueta, Rolf A. Stahel, & N. Pavlidis. (2005). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). Annals of Oncology. 16. i28–i29. 86 indexed citations
8.
Pentheroudakis, G. & N. Pavlidis. (2004). Evidence-based Oncology. Annals of Oncology. 15(2). 361–361. 3 indexed citations
9.
Pavlidis, N.. (2004). The diagnostic and therapeutic management of leptomeningeal carcinomatosis. Annals of Oncology. 15. iv285–iv291. 87 indexed citations
10.
Pentheroudakis, George, Vassiliki Malamou‐Mitsi, Evangelos Briasoulis, et al.. (2004). The neutrophil, not the tumor. Cancer. 101(8). 1767–1775. 18 indexed citations
11.
Andreopoulou, Eleni, Konstantinos Adamidis, George Fountzilas, et al.. (2002). Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.. PubMed. 22(3). 1903–8. 18 indexed citations
12.
Aravantinos, Gerasimos, Meletios Α. Dimopoulos, Dimitrios Bafaloukos, et al.. (2000). Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer. Annals of Oncology. 11(5). 607–612. 10 indexed citations
13.
Pectasides, Dimitrios, T. Economopoulos, G. Kouvatseas, et al.. (2000). Anthracycline-Based Chemotherapy of Primary Non-Hodgkin’s Lymphoma of the Testis: The Hellenic Cooperative Oncology Group Experience. Oncology. 58(4). 286–292. 21 indexed citations
14.
Skarlos, D., Dimitrios Pectasides, N. Pavlidis, et al.. (1999). Weekly Alternating Non-Cross-Resistant Chemotherapy for Small Cell Lung Cancer With a Good Prognosis. American Journal of Clinical Oncology. 22(1). 87–93. 3 indexed citations
15.
Fountzilas, George, George P. Stathopoulos, C. Nicolaides, et al.. (1999). Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group. Annals of Oncology. 10(4). 475–478. 16 indexed citations
16.
Kosmidis, P., N. Mylonakis, George Fountzilas, et al.. (1997). Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: A phase II study. Annals of Oncology. 8(7). 697–699. 29 indexed citations
17.
Bafaloukos, Dimitrios, N. Pavlidis, D. Skarlos, et al.. (1996). Recombinant Interferon ALFA-2A in Combination With Carboplatin, Vinblastine, and Bleomycin in the Treatment of Advanced Malignant Melanoma. American Journal of Clinical Oncology. 19(3). 296–300. 9 indexed citations
18.
Skarlos, Dimosthenis, Gerasimos Aravantinos, P. Kosmidis, et al.. (1996). Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a hellenic co-operative oncology group study. European Journal of Cancer. 32(3). 421–428. 13 indexed citations
19.
Verweij, Jaap, J. Wanders, Anette Lynge Nielsen, et al.. (1994). Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. Annals of Oncology. 5(4). 375–376. 9 indexed citations
20.
Cerny, Thomas, Steven Kaplan, N. Pavlidis, et al.. (1994). Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG). British Journal of Cancer. 70(2). 384–387. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Remedios Penetrante Breakdown of academic impact, for papers by Catharina Wenzel Breakdown of academic impact, for papers by Christian Borel Breakdown of academic impact, for papers by M Jouve Breakdown of academic impact, for papers by Claudia Maggi Breakdown of academic impact, for papers by Leigh Marcus Breakdown of academic impact, for papers by Isabelle Veys Breakdown of academic impact, for papers by Carlo Messina Breakdown of academic impact, for papers by V. Weinberg Breakdown of academic impact, for papers by Emer O. Hanrahan
Rankless by CCL
2026